Skip to content
10-Q

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001562884-21-000042

← back to feed
Filed
Sep 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 10, 2021 256.12M sh
Stockholders Equity Q2 2020 · Jun 30, 2020 −$28.32K
Stockholders Equity Q2 2020 · Dec 31, 2019 −$22.58K
Current Liabilities Q2 2020 · Jun 30, 2020 $28.32K
Current Liabilities Q2 2020 · Dec 31, 2019 $22.58K
Total Assets Q2 2020 · Jun 30, 2020 $0
Total Assets Q2 2020 · Dec 31, 2019 $0
Operating Cash Flow Q2 2020 · Jun 30, 2019 $0
Sga Expense restated Q2 2020 · Jun 30, 2019 $17.31K
Sga Expense restated Q2 2020 · Jun 30, 2019 $23.56K
Net Income restated Q2 2020 · Jun 30, 2019 −$17.31K
Net Income restated Q2 2020 · Jun 30, 2019 −$23.56K
Net Income Q2 2020 · Mar 31, 2019 −$6.26K
Operating Income restated Q2 2020 · Jun 30, 2019 −$17.31K
Operating Income restated Q2 2020 · Jun 30, 2019 −$23.56K
Revenue Q2 2020 · Jun 30, 2019 $0
Revenue Q2 2020 · Jun 30, 2019 $0